Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Miragen Therapeutics Inc (MGEN)

Miragen Therapeutics Inc (MGEN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
23.01 -0.02 (-0.09%) 01/19/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 23.01 unch (unch) -
Quote Overview for Tue, Jan 19th, 2021
Day Low
22.97
Day High
23.90
Open 23.29
Previous Close 23.03 23.03
Volume 44,300 44,300
Avg Vol 96,920 96,920
Stochastic %K 72.56% 72.56%
Weighted Alpha -30.55 -30.55
5-Day Change +1.08 (+4.92%) +1.08 (+4.92%)
52-Week Range 4.66 - 34.05 4.66 - 34.05
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,928
  • Shares Outstanding, K 3,908
  • Annual Sales, $ 4,460 K
  • Annual Income, $ -41,870 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.66
  • Price/Sales 47.83
  • Price/Cash Flow N/A
  • Price/Book 4.16
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.65
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/10/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -2.61
  • Number of Estimates 4
  • High Estimate -1.27
  • Low Estimate -5.67
  • Prior Year -4.65
  • Growth Rate Est. (year over year) +43.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.02 +43.59%
on 12/29/20
Period Open: 19.95
25.67 -10.36%
on 01/14/21
+3.06 (+15.34%)
since 12/18/20
3-Month
7.08 +225.00%
on 10/22/20
Period Open: 7.80
25.67 -10.36%
on 01/14/21
+15.21 (+195.00%)
since 10/19/20
52-Week
4.66 +393.25%
on 03/19/20
Period Open: 9.90
34.05 -32.42%
on 01/30/20
+13.11 (+132.42%)
since 01/17/20

Business Summary

Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder,...

See More

Key Turning Points

3rd Resistance Point 24.55
2nd Resistance Point 24.22
1st Resistance Point 23.62
Last Price 23.01
1st Support Level 22.69
2nd Support Level 22.36
3rd Support Level 21.76

See More

52-Week High 34.05
Last Price 23.01
Fibonacci 61.8% 22.82
Fibonacci 50% 19.36
Fibonacci 38.2% 15.89
52-Week Low 4.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Master Swing Trading: Strategies for Momentum and Trends